Unknown

Dataset Information

0

Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides.


ABSTRACT: Signal transduction pathways play key roles in the initiation, progression and dissemination of cancer. Thus, signaling molecules are attractive targets for cancer therapeutics and enormous efforts have gone into the development of small molecule inhibitors of these pathways. However, regrettably, there has been only moderate progress to date, primarily in connection with the RAS signaling pathway. Oligonucleotide-based drugs potentially offer several advantages for addressing signaling pathways, including their exquisite selectivity and their ability to exploit both enzymatic and nonenzymatic targets. Nonetheless, there are problems inherent in the oligonucleotide approach, not the least being the challenge of effectively delivering these complex molecules to intracellular sites within tumors. This survey article will provide a selective review of recent studies where oligonucleotides were used to address cancer signaling and will discuss both positive aspects and limitations of those studies. This will be set in the context of an overview of various cancer signaling pathways and small molecule approaches to regulate those pathways. The survey will also evaluate the challenges and opportunities implicit in the oligonucleotide-based approach to cancer signaling and will point out several possibilities for future research.

SUBMITTER: Juliano RL 

PROVIDER: S-EPMC7520847 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2740336 | biostudies-literature
| S-EPMC2712453 | biostudies-literature
| S-EPMC3407688 | biostudies-literature
2008-12-23 | GSE13350 | GEO
| S-EPMC2014792 | biostudies-literature
2008-12-23 | E-GEOD-13350 | biostudies-arrayexpress
| S-EPMC4684747 | biostudies-literature
| S-EPMC26391 | biostudies-literature
| S-EPMC3225034 | biostudies-literature
| S-EPMC4977476 | biostudies-literature